Meeting Abstract


DOI :10.26650/JARHS2021-1135830   IUP :10.26650/JARHS2021-1135830    Full Text (PDF)

DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER

Gizem Çalıbaşı Koçal

Diet influence human health in different ways. But it is well known that diet can adversely affect various human pathologies, like obesity, diabetes, hypertension, and cancer. The relationship between diet, obesity and cancer has been studied for different types of cancer such as breast, colorectal and gastric cancers. High fat diet induced obesity is an established risk factor for cancer in many tissues. In the mammalian intestine, tumorigenesis is facilitated by a pro-obesity high-fat diet (HFD) by enhancing PPAR (peroxisome proliferator-activated receptor) nuclear receptor activation. PPARs induced fatty acid oxidation increased stem cell number and tumorigenesis. The rate controlling enzyme of fatty acid oxidation, CPT1A, dampens the pro-tumorigenic phenotype by blunting HFD effect in ISCs. High-fat ketogenic diet also elevates ISC function and regeneration capacity through βOHB-mediated Notch signaling, but a glucose-supplemented diet has the opposite effects. High glucose diet also presents an indirect link between sugar and cancer. The relationship dietary supplements used in addition to the diet and cancer is frequently studied. In literature, there is strong evidence on the anticancer effects of anthocyanins, curcumin, vitamin D, and their mechanisms.


PDF View

References

    Citations

    Copy and paste a formatted citation or use one of the options to export in your chosen format


    EXPORT



    APA

    Çalıbaşı Koçal, G. (2022). DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER. Journal of Advanced Research in Health Sciences, 5(1), 32-32. https://doi.org/10.26650/JARHS2021-1135830


    AMA

    Çalıbaşı Koçal G. DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER. Journal of Advanced Research in Health Sciences. 2022;5(1):32-32. https://doi.org/10.26650/JARHS2021-1135830


    ABNT

    Çalıbaşı Koçal, G. DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER. Journal of Advanced Research in Health Sciences, [Publisher Location], v. 5, n. 1, p. 32-32, 2022.


    Chicago: Author-Date Style

    Çalıbaşı Koçal, Gizem,. 2022. “DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER.” Journal of Advanced Research in Health Sciences 5, no. 1: 32-32. https://doi.org/10.26650/JARHS2021-1135830


    Chicago: Humanities Style

    Çalıbaşı Koçal, Gizem,. DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER.” Journal of Advanced Research in Health Sciences 5, no. 1 (Dec. 2024): 32-32. https://doi.org/10.26650/JARHS2021-1135830


    Harvard: Australian Style

    Çalıbaşı Koçal, G 2022, 'DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER', Journal of Advanced Research in Health Sciences, vol. 5, no. 1, pp. 32-32, viewed 2 Dec. 2024, https://doi.org/10.26650/JARHS2021-1135830


    Harvard: Author-Date Style

    Çalıbaşı Koçal, G. (2022) ‘DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER’, Journal of Advanced Research in Health Sciences, 5(1), pp. 32-32. https://doi.org/10.26650/JARHS2021-1135830 (2 Dec. 2024).


    MLA

    Çalıbaşı Koçal, Gizem,. DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER.” Journal of Advanced Research in Health Sciences, vol. 5, no. 1, 2022, pp. 32-32. [Database Container], https://doi.org/10.26650/JARHS2021-1135830


    Vancouver

    Çalıbaşı Koçal G. DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER. Journal of Advanced Research in Health Sciences [Internet]. 2 Dec. 2024 [cited 2 Dec. 2024];5(1):32-32. Available from: https://doi.org/10.26650/JARHS2021-1135830 doi: 10.26650/JARHS2021-1135830


    ISNAD

    Çalıbaşı Koçal, Gizem. DIETARY-BASED MOLECULAR TARGETS AND THERAPEUTIC OPPORTUNITIES IN CANCER”. Journal of Advanced Research in Health Sciences 5/1 (Dec. 2024): 32-32. https://doi.org/10.26650/JARHS2021-1135830



    TIMELINE


    Published Online09.08.2022

    LICENCE


    Attribution-NonCommercial (CC BY-NC)

    This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


    SHARE




    Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.